Retinal Gene Delivery by rAAV and DNA Electroporation
Open accessThe DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Abstract
Ocular gene therapy is a fast‐growing area of research. The eye is an ideal organ for gene therapy since it is immune privileged and easily accessible, and direct viral delivery results primarily in local infection. Because the eye is not a vital organ, mutations in eye‐specific genes tend to be more common. To date, over 40 eye‐specific genes have been identified harboring mutations that lead to blindness. Gene therapy with recombinant adeno‐associated virus (rAAV) holds the promise to treat patients with such mutations. However, proof‐of‐concept and safety evaluation for gene therapy remains to be established for most of these diseases. This unit describes the in vivo delivery of genes to the mouse eye by rAAV‐mediated gene transfer and plasmid DNA electroporation. Advantages and limitations of these methods are discussed, and detailed protocols for gene delivery, required materials, and subsequent tissue processing methods are described. Curr. Protoc. Microbiol. 28:14D.4.1‐14D.4.32. © 2013 by John Wiley & Sons, Inc.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Safety and Efficacy of Gene Transfer for Leber's Congenital Amaurosis
Maguire, A. M., Simonelli, F., Pierce, E. A., Pugh, E. N., Mingozzi, F., Bennicelli, J., Banfi, S., Marshall, K. A., Testa, F., Surace, E. M., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802315 · Cited by 2,145 · cited 1×
“Delivery of the RPE65 gene by rAAV to the RPE of individuals suffering from LCA-2 has restored vision in blind people (Bainbridge et al., 2008; Maguire et al., 2008), giving hope to many others suffering from vision loss.”
BackgroundEffect of gene therapy on visual function in Leber’s congenital amaurosis
Bainbridge, J. W. B., Smith, A. J., Barker, S. S., Robbie, S., Henderson, R., Balaggan, K., Viswanathan, A., Holder, G. E., Stockman, A., Tyler, N., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802268 · Cited by 1,924 · cited 1×
“Delivery of the RPE65 gene by rAAV to the RPE of individuals suffering from LCA-2 has restored vision in blind people (Bainbridge et al., 2008; Maguire et al., 2008), giving hope to many others suffering from vision loss.”
BackgroundGene therapy restores vision in a canine model of childhood blindness
Acland, G. M., Aguirre, G. D., Ray, J., Zhang, Q., Aleman, T. S., Cideciyan, A. V., Pearce-Kelling, S. E., Anand, V., Zeng, Y., Maguire, A. M., et al. (2001) · Nature Genetics · doi:10.1038/ng0501-92 · Cited by 1,202
Mutations in RPE65 cause autosomal recessive childhood–onset severe retinal dystrophy
Gu, S.-M., Thompson, D. A., Srikumari, C. R. S., Lorenz, B., Finckh, U., Nicoletti, A., Murthy, K. R., Rathmann, M., Kumaramanickavel, G., Denton, M. J., et al. (1997) · Nature Genetics · doi:10.1038/ng1097-194 · Cited by 663 · cited 4×
“Mutations in RPE65 cause Leber’s congenital amaurosis.”
BackgroundInfluentialMutations in RPE65 cause Leber's congenital amaurosis
Marlhens, F., Bareil, C., Griffoin, J.-M., Zrenner, E., Amalric, P., Eliaou, C., Liu, S.-Y., Harris, E., Redmond, T. M., Arnaud, B., et al. (1997) · Nature Genetics · doi:10.1038/ng1097-139 · Cited by 606 · cited 1×
“LCA-2 is an early-onset disease caused by a mutation in the RPE protein RPE65 (Gu et al., 1997; Marlhens et al., 1997).”
BackgroundThe Cone-specific visual cycle
Wang, J.-S., & Kefalov, V. J. (2011) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2010.11.001 · Cited by 335 · cited 1×
“It provides nutrients and oxygen for PRs and is involved in the visual cycle (Parker and Crouch, 2010; Wang and Kefalov, 2011).”
BackgroundRetinol dehydrogenases (RDHs) in the visual cycle
Parker, R. O., & Crouch, R. K. (2010) · Experimental Eye Research · doi:10.1016/j.exer.2010.08.013 · Cited by 173 · cited 1×
“It provides nutrients and oxygen for PRs and is involved in the visual cycle (Parker and Crouch, 2010; Wang and Kefalov, 2011).”
Background
Cited by
Zhang, W., Li, L., Su, Q., Gao, G., & Khanna, H. (2018) · Human Gene Therapy · doi:10.1089/hum.2017.049 · Cited by 60
“35,36 Electroretinogram and immunofluorescence microscopy of the retina Scotopic and photopic electroretinograms (ERGs) were performed, as previously reported.”
MethodSelf-citationSalman, A., Kantor, A., McClements, M. E., Marfany, G., Trigueros, S., & MacLaren, R. E. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14091842 · Cited by 37
Gene Therapy for Inherited Retinal Degeneration
Arbabi, A., Liu, A., & Ameri, H. (2019) · Journal of Ocular Pharmacology and Therapeutics · doi:10.1089/jop.2018.0087 · Cited by 30
“111,112 However, there are safety concerns with electroporation; in addition, because of the size of the human eye, the application of electroporation is significantly more challenging in the human eye compared to that of the rodents.”
Petit, L., Ma, S., Cheng, S.-Y., Gao, G., & Punzo, C. (2017) · Human Gene Therapy · doi:10.1089/hum.2017.020 · Cited by 24
“41 In this study, the rate of rod transduction after injection at PND21 was limited to 30–55%, while other groups have reported PR transduction rates of > 90% within the vector exposed area.”
InfluentialSelf-citationCheng, S.-Y., Luo, Y., Malachi, A., Ko, J., Su, Q., Xie, J., Tian, B., Lin, H., Ke, X., Zheng, Q., et al. (2021) · Human Gene Therapy · doi:10.1089/hum.2021.132 · Cited by 14
“38,39 In brief, eye cups were dissected in cold 1 · phosphate-buffered saline (PBS) and fixed in 4% paraformaldehyde overnight at 4 (cid:2) C. Cryosections were cut at 12 l m thickness.”
Self-citation
Metadata
- Authors
- Venkatesh, A., Ma, S., Langellotto, F., Gao, G., & Punzo, C.
- Venue
- Current Protocols in Microbiology
- Publisher
- Wiley
- Published
- 2013-02
- Volume
- 28
- Issue
- 1
- Pages
- Unit 14D.4-Unit 14D.4
- ISSN
- 1934-8525 (ISSN-L)
- 1934-8533
- OpenAlex
- W1746435868
- Cited by
- 35
- References
- 7
- FWCI
- 1.48
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Retinal Gene Delivery by rAAV and DNA Electroporation. https://app.cochat.ai/papers/10.1002/9780471729259.mc14d04s28
- The paper
- Venkatesh, A., Ma, S., Langellotto, F., Gao, G., & Punzo, C. (2013). Retinal Gene Delivery by rAAV and DNA Electroporation. Current Protocols in Microbiology. https://doi.org/10.1002/9780471729259.mc14d04s28
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.